Last reviewed · How we verify
Vonoprazan+amoxicillin+clarithromycin 7 days
Vonoprazan+amoxicillin+clarithromycin 7 days is a Proton pump inhibitor (vonoprazan) + beta-lactam antibiotic (amoxicillin) + macrolide antibiotic (clarithromycin) Small molecule drug developed by Xijing Hospital of Digestive Diseases. It is currently FDA-approved for Helicobacter pylori eradication in peptic ulcer disease and gastritis.
This triple-therapy combination eradicates Helicobacter pylori by suppressing gastric acid (vonoprazan) while simultaneously killing the bacteria with two antibiotics (amoxicillin and clarithromycin).
This triple-therapy combination eradicates Helicobacter pylori by suppressing gastric acid (vonoprazan) while simultaneously killing the bacteria with two antibiotics (amoxicillin and clarithromycin). Used for Helicobacter pylori eradication in peptic ulcer disease and gastritis.
At a glance
| Generic name | Vonoprazan+amoxicillin+clarithromycin 7 days |
|---|---|
| Sponsor | Xijing Hospital of Digestive Diseases |
| Drug class | Proton pump inhibitor (vonoprazan) + beta-lactam antibiotic (amoxicillin) + macrolide antibiotic (clarithromycin) |
| Target | H+/K+-ATPase (vonoprazan); bacterial cell wall and ribosome (amoxicillin and clarithromycin) |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology / Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
Vonoprazan is a potassium-competitive acid blocker (PCAB) that inhibits the proton pump to reduce gastric acid, creating an optimal environment for antibiotic efficacy. Amoxicillin and clarithromycin are bactericidal and bacteriostatic antibiotics, respectively, that target bacterial cell wall synthesis and protein synthesis. Together, the reduced acid environment and dual antibiotic attack achieve high eradication rates of H. pylori infection.
Approved indications
- Helicobacter pylori eradication in peptic ulcer disease and gastritis
Common side effects
- Diarrhea
- Nausea
- Abdominal discomfort
- Taste disturbance
- Headache
Key clinical trials
- Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy (PHASE4)
- 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication (PHASE3)
- Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication (PHASE4)
- Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential Therapy (PHASE4)
- Vonoprazan Hp Dual or Triple Eradication Regimes (PHASE4)
- 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy (PHASE4)
- A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis (PHASE4)
- Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vonoprazan+amoxicillin+clarithromycin 7 days CI brief — competitive landscape report
- Vonoprazan+amoxicillin+clarithromycin 7 days updates RSS · CI watch RSS
- Xijing Hospital of Digestive Diseases portfolio CI
Frequently asked questions about Vonoprazan+amoxicillin+clarithromycin 7 days
What is Vonoprazan+amoxicillin+clarithromycin 7 days?
How does Vonoprazan+amoxicillin+clarithromycin 7 days work?
What is Vonoprazan+amoxicillin+clarithromycin 7 days used for?
Who makes Vonoprazan+amoxicillin+clarithromycin 7 days?
What drug class is Vonoprazan+amoxicillin+clarithromycin 7 days in?
What development phase is Vonoprazan+amoxicillin+clarithromycin 7 days in?
What are the side effects of Vonoprazan+amoxicillin+clarithromycin 7 days?
What does Vonoprazan+amoxicillin+clarithromycin 7 days target?
Related
- Drug class: All Proton pump inhibitor (vonoprazan) + beta-lactam antibiotic (amoxicillin) + macrolide antibiotic (clarithromycin) drugs
- Target: All drugs targeting H+/K+-ATPase (vonoprazan); bacterial cell wall and ribosome (amoxicillin and clarithromycin)
- Manufacturer: Xijing Hospital of Digestive Diseases — full pipeline
- Therapeutic area: All drugs in Gastroenterology / Infectious Disease
- Indication: Drugs for Helicobacter pylori eradication in peptic ulcer disease and gastritis
- Compare: Vonoprazan+amoxicillin+clarithromycin 7 days vs similar drugs
- Pricing: Vonoprazan+amoxicillin+clarithromycin 7 days cost, discount & access